304 related articles for article (PubMed ID: 32903043)
1. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
3. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.
Duncan JKS; Xu D; Licursi M; Joyce MA; Saffran HA; Liu K; Gohda J; Tyrrell DL; Kawaguchi Y; Hirasawa K
Front Immunol; 2023; 14():930086. PubMed ID: 37197656
[TBL] [Abstract][Full Text] [Related]
5. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
[TBL] [Abstract][Full Text] [Related]
6. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
7. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
Chan RW; Chan MC; Agnihothram S; Chan LL; Kuok DI; Fong JH; Guan Y; Poon LL; Baric RS; Nicholls JM; Peiris JS
J Virol; 2013 Jun; 87(12):6604-14. PubMed ID: 23552422
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
9. Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
Otter CJ; Renner DM; Fausto A; Tan LH; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2402540121. PubMed ID: 38758698
[TBL] [Abstract][Full Text] [Related]
10. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
11. Antiviral strategies against human coronaviruses.
Pyrc K; Berkhout B; van der Hoek L
Infect Disord Drug Targets; 2007 Mar; 7(1):59-66. PubMed ID: 17346212
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
14. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
Jeon YJ; Gil CH; Jo A; Won J; Kim S; Kim HJ
Antiviral Res; 2020 Aug; 180():104860. PubMed ID: 32565134
[TBL] [Abstract][Full Text] [Related]
15. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
[TBL] [Abstract][Full Text] [Related]
16. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S
Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
[TBL] [Abstract][Full Text] [Related]
18. Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids.
Li P; Wang Y; Lamers MM; Lavrijsen M; Iriondo C; de Vries AC; Rottier RJ; Peppelenbosch MP; Haagmans BL; Pan Q
EBioMedicine; 2022 Jul; 81():104132. PubMed ID: 35779493
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
20. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.
Chan KH; Cheng VC; Woo PC; Lau SK; Poon LL; Guan Y; Seto WH; Yuen KY; Peiris JS
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1317-21. PubMed ID: 16275947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
